SAN DIEGO, April 9, 2012 /PRNewswire/ -- Optimer Pharmaceuticals (NASDAQ: OPTR) ("the Company" or "Optimer") today announced its Board of Directors has appointed Hank McKinnell as its

DEERFIELD, Ill., April 5, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc.

SAN DIEGO and TOKYO, March 29, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Tokyo-based Astellas Pharma Inc.

Partnership establishes grant to advance urology research in Canada MARKHAM, ON, March 28, 2012 /PRNewswire/ - The Canadian Urological Association (CUA) and Astellas Pharma

Josh Schafer, a speaker at the marcus evans PharmaMarketing Summit 2012, on more effective pharmaceutical marketing.New York, Mar 28, 2012 - (ACN Newswire) - "Pharmaceutical